Wednesday, June 29, 2011
1:00 p.m. to 2:30 p.m. ET

There are a variety of drug treatments available for people living with osteoporosis. On Wednesday, June 29, 2011, Dr. Rowena Ridout will be reviewing currently approved therapies for osteoporosis in Canada, more specifically oral and IV bisphosphonates, raloxifene, denosumab, calcitonin, hormone therapy and parathyroid hormone. Dr. Ridout, a member of the Scientific Advisory Council (SAC), will also be addressing some of the recent concerns about bisphosphonates. This virtual education forum will offer valuable up-to-date information about medications and osteoporosis.

Register for this event and have your questions answered by Dr. Ridout in real-time.

Time Zones
PT: 10.00 a.m. to 11:30 p.m.
MT: 11:30 p.m. to 12:30 p.m.
CT: 12:00 p.m. to 1:30 p.m.
ET: 1:00 p.m. to 2:30 p.m.
AT: 2:00 p.m. to 3:30 p.m.

View in the comfort of your own home or office. Do you have the system requirements? Test your system by clicking on:
http://www.rocket9broadcasting.com/systemtest/resolve/

Dr. Ridout is an endocrinologist at the Toronto Western Hospital, University Health Network. She completed her undergraduate and postgraduate medical training at the University of Toronto. She is an Assistant Professor of Medicine at the University of Toronto. Her primary academic activity is teaching and education. In the past she has been involved in clinical research in osteoporosis including the attainment and maintenance of peak bone mass, the treatment of steroid-induced osteoporosis in children and interventions in the fracture clinic. She is Associate Director of the Osteoporosis Program at the University Health Network and is a member of the Scientific Advisory Council of Osteoporosis Canada.